Effect of Acupuncture on the Motor and Nonmotor Symptoms in Parkinson's Disease — A Review of Clinical Studies
Zeng et al. · CNS Neuroscience & Therapeutics · 2016
Evidence Level
MODERATEOBJECTIVE
To review clinical studies on acupuncture for the treatment of motor and nonmotor symptoms of Parkinson's disease
WHO
519 patients with Parkinson's disease across 14 clinical studies
REVIEW
15 years of research (2000-2014)
POINTS
GB-34, ST-36, LR-3, KI-3 were the most commonly used in the studies
🔬 Study Design
Manual Acupuncture
n=200
traditional needling at specific points
Electroacupuncture
n=240
electrical stimulation at acupuncture points
Control/Medication
n=79
medication or placebo only
📊 Results in numbers
Improvement in motor symptoms
Improvement in depression
Improvement in sleep disturbances
Reduction in levodopa dosage
Percentage highlights
📊 Outcome Comparison
UPDRS III scores (motor function)
Nonmotor Symptoms
This review shows that acupuncture may be a promising treatment for people with Parkinson's disease, especially for symptoms such as depression, sleep problems, and digestive difficulties. When used together with conventional medications, acupuncture may improve outcomes and reduce the need for higher doses of levodopa.
Article summary
Plain-language narrative summary
This comprehensive review examined 15 years of clinical research on the use of acupuncture in the treatment of Parkinson's disease (PD), analyzing data from 519 patients across 14 clinical studies. Parkinson's disease is a progressive neurodegenerative disorder that affects more than 1 in 1,000 people over age 60, characterized not only by motor symptoms such as tremor and rigidity but also by a broad range of nonmotor symptoms that frequently precede the motor symptoms and have a more profound impact on patients' quality of life. The review included studies conducted in the United States, Korea, and China, using rigorous selection criteria focused on penetrating acupuncture with manual or electrical stimulation. Results revealed that acupuncture, both manual and electroacupuncture, demonstrated significant efficacy in relieving motor symptoms of PD.
Seven studies used the Unified Parkinson's Disease Rating Scale (UPDRS), with four showing moderate to marked improvement in UPDRS III motor scores. Notably, one study using functional magnetic resonance imaging demonstrated that stimulation of point GB-34 activated movement-related brain regions, including the putamen and primary motor cortex, providing neurobiological evidence of the mechanism of action of acupuncture. Nonmotor symptoms showed an even more impressive response to acupuncture treatment. Depression, one of the most common and debilitating nonmotor symptoms of PD, showed significant improvement in all studies that evaluated it, with consistent reduction in Beck Depression Inventory scores.
Sleep disturbances, which affect up to 50% of PD patients, also responded favorably, with 85% of patients reporting subjective improvement in sleep problems. Gastrointestinal symptoms, particularly constipation and nausea, showed substantial improvement without adverse effects. Bladder dysfunction, another common autonomic symptom, also showed significant improvement with acupuncture treatment. A clinically relevant finding was that when acupuncture was used as an adjunct to levodopa, it not only improved therapeutic efficacy but also allowed for reduction of dosage and decrease in medication side effects.
Some studies reported that up to 87% of patients were able to interrupt medication for two weeks after acupuncture treatment, while maintaining good symptom improvement. The most frequently used acupuncture points were GB-34 (Yanglingquan), ST-36 (Zusanli), LR-3 (Taichong), and KI-3 (Taixi), with about 40 different body points employed across the various studies. The technique called 'Seven Points at the Base of the Skull' (GV-15, bilateral BL-10, GB-20, and GB-12) showed particularly promising results. However, the review identified significant methodological limitations that restrict the reliability of the results.
Eight of the 14 studies did not present adequate diagnostic criteria, only two were single-blind controlled studies, and only one was double-blind controlled. Lack of appropriate control groups, small sample sizes, and inconsistency in outcome measures were recurrent problems. In addition, most studies did not mention adverse effects or dropouts during treatment. Duration and frequency of treatment varied considerably across studies, suggesting that standardized protocols are needed.
Despite these limitations, the data suggest that acupuncture has promising therapeutic potential for PD, especially for nonmotor symptoms that respond poorly to conventional dopaminergic treatment. Clinical implications include the possibility of using acupuncture as adjunctive therapy to improve patients' quality of life and potentially reduce dependence on medications. The authors recommend that future studies follow rigorous methodological guidelines, include adequate sample sizes based on appropriate pilot studies, use standardized outcome measures, and include follow-up assessments to determine the sustainability of therapeutic effects. Comparative-effectiveness research and high-quality placebo-controlled studies are needed to definitively establish the role of acupuncture in the management of Parkinson's disease.
Strengths
- 1Comprehensive review of 15 years of clinical research
- 2Analysis of both motor and nonmotor symptoms
- 3Neurobiological evidence from fMRI studies
- 4Large total number of participants (519 patients)
- 5Identification of specific, most effective acupuncture points
Limitations
- 1Limited methodological quality of most studies
- 2Lack of double-blind placebo-controlled studies
- 3Inconsistency in outcome measures used
- 4Varied treatment protocols across studies
- 5Absence of long-term follow-up data
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
Parkinson's disease confronts the neurologist and physiatrist with a problem of chronic management that goes well beyond the dopaminergic axis. Nonmotor symptoms — depression, sleep disturbances, constipation, autonomic dysfunction — respond poorly to levodopa and account for much of the morbidity burden perceived by the patient. This review of 519 patients, covering 15 years of clinical production, positions acupuncture as an adjunct with a favorable benefit profile precisely in this neglected spectrum. Patients in the early to moderate stages, with prominent nonmotor symptoms and levodopa doses still being titrated, represent the most immediate target. The documented possibility of reducing levodopa dosage — with consequent attenuation of dyskinesias and on-off phenomena — adds real pharmacoeconomic value to the armamentarium of neurological rehabilitation centers that already work with a structured multiprofessional team.
▸ Notable Findings
Two findings deserve special attention from those who work in neurorehabilitation. The first is the disproportionate response of nonmotor symptoms relative to motor symptoms: depression and sleep disturbances reached 85% improvement, exceeding the 70% observed in motor symptoms assessed by UPDRS III. This inverts the intuitive expectation of those who associate acupuncture with musculoskeletal modulation. The second is the neurobiological support provided by the fMRI study demonstrating activation of the putamen and primary motor cortex after stimulation of point GB-34, providing mechanistic substrate to the clinical observation. The 'Seven Points at the Base of the Skull' technique and the recurrence of points such as GB-34, ST-36, LR-3, and KI-3 in the most effective protocols offer a rational starting point for standardization of protocols in services that have not yet incorporated acupuncture into Parkinson's care.
▸ From My Experience
In my practice in neurological rehabilitation, I have incorporated acupuncture in Parkinson's disease especially when the patient presents with a chief complaint of insomnia, refractory constipation, or subclinical depression that the neurologist has not yet medicated separately. I usually observe response in sleep disturbances within the first four to six sessions — which aligns with what this review documents and which, honestly, is the easiest argument to make with the patient. For motor symptoms, the expectation is more modest and generally manifests between the eighth and twelfth session, usually as softening of axial rigidity and improved gait perceived by the physical therapist. I combine electroacupuncture at GB-34 with manual acupuncture at ST-36 and LR-3, always combined with motor physiotherapy. I do not indicate acupuncture as a stand-alone intervention or in patients with established dementia, where cooperation with the procedure is compromised. The profile that responds best, in my experience, is the patient with less than five years since diagnosis, good adherence to overall treatment, and a predominant burden of nonmotor symptoms.
Full original article
Read the full scientific study
CNS Neuroscience & Therapeutics · 2016
DOI: 10.1111/cns.12507
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories